Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > Safety Info > Safety Communication > Safety Alerts > Safety Alert of Risk of Circulatory Shock with the Sulfamethoxazole and trimethoprim drug combination

Safety Alert of Risk of Circulatory Shock with the Sulfamethoxazole and trimethoprim drug combination

Abdul Mateen Safety Alerts February 6, 2026February 6, 2026
64-Safety-Alert-of-Risk-of-Circulatory-Shock-with-the-Sulfamethoxazole-and-trimethoprim-drug-combinationDownload

Share this:

  • Twitter
  • Facebook
  • ← Safety Alert of Potential Risk of Suicidal Thoughts with Finasteride and Dutasteride-containing medicines
  • Safety Alert of Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) with Semaglutide →
  • Product Recalls
    • Recall Alerts
    • Therapeutic Products Recalls
    • Recalls and Rapid Alerts
  • Safety Communication
    • Safety Alerts
    • Health Professional Alerts
    • Pharmacovigilance Newsletter
  • Safety Reporting
    • How DRAP Monitor Safety
    • Adverse Events Reporting
    • Pharmacovigilance System
    • Product Quality Defects

Quick Navigation

  • Registered Drugs Index
  • Drug Pricing Index
  • List of Pharmaceutical Units

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem